Beta trial to evaluate the preliminary clinical performance of the Curian S. pneumo/Legionella assay for its use in the qualitative detection of Streptococcus pneumoniae and/or Legionella pneumophila serogroup 1 antigens in human urine specimens.
This study will evaluate the preliminary clinical performance of the RUO Curian S. pneumo/Legionella assay against two FDA cleared comparators for its use in the qualitative detection of Streptococcus pneumoniae and/or Legionella pneumophila serogroup 1 antigens in human urine specimens.
Study Type
OBSERVATIONAL
Enrollment
199
There is no intervention.
Indiana University
Indianapolis, Indiana, United States
Agreement between Curian S. pneumo/Legionella Assay and two cleared FDA assays
Curian S. pneumo/Legionella Assay will be compared to the comparator assays (both FDA cleared)
Time frame: 7 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.